LONGEVITY 1

Clinical trials for LONGEVITY 1 explained in plain language.

Never miss a new study

Get alerted when new LONGEVITY 1 trials appear

Sign up with your email to follow new studies for LONGEVITY 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Aging on pause? new trial tests tirzepatide as a biological clock stopper

Disease control Recruiting now

This study tests whether the weight-loss drug tirzepatide can slow biological aging in 90 adults aged 55-70. Participants will receive weekly injections or no drug for 24 weeks, then be followed for 12 more weeks. The focus is on changes in DNA-based aging markers, not weight los…

Matched conditions: LONGEVITY 1

Phase: PHASE2 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

LONGEVITY 1

Get alerted when new LONGEVITY 1 trials appear

Aging on pause? new trial tests tirzepatide as a biological clock stopper